SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458508091260v1
14/7/972    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wynia, K
Right arrow Articles by Reijneveld, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wynia, K
Right arrow Articles by Reijneveld, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

research-article

The impact of disabilities on quality of life in people with multiple sclerosis

K Wynia

Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands k.wynia{at}neuro.umcg.nl

B Middel

Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Oral Health and Clinical Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

JP van Dijk

Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

JHA De Keyser

Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

SA Reijneveld

Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Objective

People with Multiple Sclerosis (MS) experience lower levels of quality of life (QOL) than people from the general population. We examined the relative impact of MS-related disabilities on QOL.

Method

Data were obtained from a sample of 530 patients who completed the Multiple Sclerosis Impact Profile (MSIP), a disability measure based on the International Classification of Functioning,Disabilities and Health (ICF) and two generic health-related QOL measures, the Medical Outcome study Short Form Questionnaire (SF-36) and the World Health Organization Quality Of Life-BREF (WHOQOL-BREF). The impact of disabilities on QOL was estimated using hierarchical multiple regression analyses after controlling for the clinical course of MS.

Results

Disabilities contributed to a unique and substantial extent to QOL variance. "Impairments in mental functions" was the most important QOL predictor. "Fatigue" showed the highest prevalence and severity scores, while the impact on QOL was limited. The estimated impact on QOL appeared to be dependent on the applied QOL measure: the WHOQOL-BREF was sensitive to disabilities related to all four ICF components, while the SF-36 was only sensitive to disabilities belonging to the 'body functions' and ‘activities' components.

Conclusion

Treatment programmes should target impairments in cognitive functioning, emotional functioning and sleep. Interventions are best evaluated using the WHOQOL-BREF.

Key Words: disability • international classification of functioning • disabilities and health • multiple sclerosis • Multiple Sclerosis Impact Profile • quality of life

This version was published on August 1, 2008

Multiple Sclerosis, Vol. 14, No. 7, 972-980 (2008)
DOI: 10.1177/1352458508091260


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
F. E Munschauer III, R. H. Benedict, C. V Granger, and P. M Niewczyk
Introduction to Best practice recommendations for the selection and management of patients with MS on natalizumab
Multiple Sclerosis, November 1, 2009; 15(4_suppl): S1 - S6.
[PDF]


Home page
Mult SclerHome page
S. Morrow, B Weinstock-Guttman, F. Munschauer, D Hojnacki, and R. Benedict
Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis
Multiple Sclerosis, August 1, 2009; 15(8): 998 - 1005.
[Abstract] [PDF]


Home page
NeurologyHome page
J. F. Foley and D. W. Brandes
Redefining functionality and treatment efficacy in multiple sclerosis
Neurology, June 9, 2009; 72(23_Supplement_5): S1 - S11.
[Abstract] [Full Text] [PDF]



Advertisement